Pharm
Propranolol
search
Propranolol
, Inderal
See Also
Beta Blocker
Background
Propranolol was the first
Beta Blocker
, developed in the 1960s by James Black
Dr. Black later won the Nobel Prize in 1988 for
Beta Blocker
development
Indications
Primary
Migraine Headache Prophylaxis
Esophageal Varices
Prevention of Recurrent Bleeding (not FDA approved)
Essential Tremor
Thyrotoxicosis
(
Hyperthyroidism
) (not FDA approved)
Performance Anxiety
(not FDA approved)
Perioperative
Pheochromocytoma
Management
Must be used with alpha blocker
Other indications for which Selective
Beta Blocker
s Preferred instead of Propranolol
Hypertension
Atrial Fibrillation Rate Control
Mechanism
Non-Selective
Beta Blocker
Beta 1 Adrenergic Receptor
Antagonist
Decreases
Heart Rate
,
Cardiac Output
, and
Sympathetic System
output (decreased renin release)
Prolongs AV conduction and refractory period
Beta 2 Adrenergic Receptor
Antagonist
Risk of bronchoconstriction
Precautions
Patients may have very different responses to various formulations (regular, LA, XL)
Dosing
Primary Indications
Migraine Headache Prophylaxis
Regular: Start 40 mg orally twice daily
XR/LA: 80 mg orally daily
Maximum: 240 mg/day)
Pheochromocytoma
Surgery
Must be used concurrently with alpha blocker
Start three days before surgery: 60 mg orally two to three times daily
Essential Tremor
Start 40 mg orally twice daily
Target 120 to 320 mg/day
Thyrotoxicosis
(not FDA approved)
Start 60 to 80 mg orally every 4 hours OR
Start 0.5 to 1 mg IV over 10 minutes every 3 hours
Esophageal Varices
Prevention of Recurrent Bleeding (not FDA approved)
Start 20 to 40 mg orally twice daily
Titrate up to 180 mg twice daily as needed, targeting
Heart Rate
drop of 25% from baseline
Performance Anxiety
(not FDA approved)
Take 20-40 mg orally as needed 45 minutes before performance
Dosing
Other Indications
Rarely Used for
Hypertension
,
Angina
or SVT management
Propranolol has been replaced by newer, selective
Beta Blocker
s for these indications
As the first
Beta Blocker
developed, Propranolol has historical indications for
Hypertension
, CAD and a fib RVR
Hypertension
Propranolol (regular release)
Start 20 to 40 mg orally twice daily
Target 160 to 480 mg/day
Maximum 640 mg/day
Propranolol LA (long acting)
Start 60 to 80 mg orally at bedtime
Target 120 to 160 mg daily
Maximum 640 mg/day
Angina
Propranolol (regular release)
Start 10 to 20 mg orally three to four times daily
Target 160 to 240 mg/day
Maximum 320 mg/day
Propranolol LA (long acting)
Start 80 mg orally at bedtime
Target 160 to 240 mg/day
Maximum 320 mg/day
Atrial Fibrillation Rate Control
Start 10 to 30 mg orally three to four times daily
Intravenous Dosing in life threatening
Arrhythmia
(very rare use)
Avoid in
Hypertensive Emergency
Load: 1-3 mg IV over 2-5 minutes
May repeat once in 2 minutes (to a total maximum up to 0.1 mg/kg)
Sustained response for 6-8 hours (do not give additional doses for 4 hours)
Adverse Effects
See
Beta Blocker
Transient
Hypertension
Beta 2 Adrenergic Receptor
Antagonist
s transiently constrict large arteries
Rebound
Hypertension
Sudden discontinuation of Propranolol
CNS Adverse Effects
CNS penetration
Congestive Heart Failure
Exacerbation
May worsen acute, decompensated CHF
Safety
Pregnancy Category C
Consider safe in
Lactation
Pharmacokinetics
Protein
bound 90%
Hepatic metabolism and renal excretion
Drug Interactions
Cimetidine
Increases Propanolol serum levels
Alcohol
Acute
Alcohol Intoxication
increases Propranolol levels
Chronic
Alcohol
use decreases Propranolol levels
Digoxin
Fatal Third degree
AV Block
has occurred
Resources
Propranolol Tablet (DailyMed)
https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0d5ac315-df2b-4b3a-bc7e-ad04752865c4
Propranolol Injection (DailyMed)
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f14ea537-dd5c-4c78-9037-9a85e9e610ef
Propranolol LA (DailyMed)
https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=35d28979-36b1-4630-b85e-a44e0a443734
Propranolol Solution (DailyMed)
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8fe0a04c-bf5b-4ba0-9df6-58c27f24b52e
References
Olson (2020) Clinical
Pharmacology
, Medmaster Miami, p. 78-9
Hamilton (2020) Tarascon Pocket Pharmacopoeia
Type your search phrase here